Johnson & Johnson (NY:JNJ)

256.03 -2.63 (-1.02%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

The 'Beautiful' Boom: How the 2025 Tax Overhaul is Fueling a 2026 Corporate Spending Spree

January 14, 2026

As the first quarter of 2026 unfolds, the American corporate landscape is undergoing a massive transformation, driven by the legislative shockwaves of the "One Big Beautiful Bill Act" (OBBBA) of July...

Via MarketMinute

The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound

January 13, 2026

For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Court Orders Recalculation Of Damages In Johnson & Johnson Auris Case ↗

January 13, 2026

Delaware's top court overturned part of a $1 billion damages award against Johnson & Johnson in the Auris Health merger, ordering a recalculation that could lower payouts.

Via Benzinga

The Evolution of a Giant: A Deep Dive into the ‘New’ Johnson & Johnson (JNJ) in 2026

January 13, 2026

As of January 13, 2026, Johnson & Johnson (NYSE: JNJ) stands at a pivotal juncture in its nearly 140-year history. Once a sprawling conglomerate synonymous with baby shampoo and Band-Aids, the "New...

Via PredictStreet

Topics Artificial Intelligence Bankruptcy Economy

2 No-Brainer Dividend Stocks to Buy Right Now ↗

January 13, 2026

More than 60 straight years of increasing dividends reflects a strong commitment behind these stocks.

Via The Motley Fool

Topics World Trade

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

This ETF Is Proof That the Healthcare Rebound Is Real ↗

January 11, 2026

Via MarketBeat

Topics ETFs

2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio ↗

January 09, 2026

Add some stability to your holdings with these healthcare giants.

Via The Motley Fool

Topics Economy Intellectual Property Lawsuit

The Grinch Who Stole Wall Street: Santa Claus Rally Fails for Third Straight Year, Echoing 1950s Slump

January 09, 2026

As the final trading bell of January 5, 2026, echoed across the floor of the New York Stock Exchange, a chilling realization set in for market historians and retail investors alike: the legendary...

Via MarketMinute

Topics Artificial Intelligence Economy

The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)

January 09, 2026

As of January 9, 2026, Eli Lilly and Company (NYSE:LLY) has transitioned from a stalwart of the American pharmaceutical industry to a global financial phenomenon. Having recently crossed the historic...

Via PredictStreet

Topics Earnings Economy Intellectual Property

Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts ↗

January 09, 2026

Johnson & Johnson struck a deal with the Trump administration to lower drug prices for U.S. consumers in exchange for exemptions from tariffs.

Via Benzinga

Topics Government

J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗

January 08, 2026

Via Stocktwits

Topics Government

Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments

January 08, 2026

From Johnson & Johnson

Via Business Wire

Johnson’s Junk Removal Launches Full-Service Junk Removal in Kenmore

January 08, 2026

Via Get News

The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader

January 08, 2026

The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood...

Via MarketMinute

Topics Intellectual Property

Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

January 07, 2026

From Johnson & Johnson

Via Business Wire

The Smartest Dividend Stocks to Buy With $3,000 Right Now ↗

January 07, 2026

It's not too late to reshape and optimize your portfolio for what could be a very different market environment than last year's.

Via The Motley Fool

Harvard’s CHIEF AI: The ‘Swiss Army Knife’ of Pathology Achieving 98% Accuracy in Cancer Diagnosis

January 06, 2026

In a landmark achievement for computational medicine, researchers at Harvard Medical School have developed a "generalist" artificial intelligence model that is fundamentally reshaping the landscape of...

Via TokenRing AI

Topics Artificial Intelligence

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment ↗

January 06, 2026

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

Via Benzinga

The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026

January 06, 2026

As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗

January 05, 2026

Via MarketBeat

Topics Artificial Intelligence Death

3 High-Yielding Dividend Kings to Buy in January for Safe Passive Income in 2026 and Beyond ↗

January 05, 2026

These companies pay high-yielding and steadily rising dividends.

Via The Motley Fool

2 Healthcare Stocks to Buy in a Bear Market ↗

January 03, 2026

They can help you weather the storm.

Via The Motley Fool

Topics Economy

Dividend Growers: 3 Stocks That Could Be Worth $1 Million in 36 Years. ↗

January 03, 2026

These dividends should continue growing.

Via The Motley Fool

Santa’s Empty Sleigh: Why the 2025 Rally Failure Signals a Rough Q1 for Wall Street

January 02, 2026

The highly anticipated "Santa Claus Rally" of 2025 has officially failed to materialize, leaving investors with a lump of coal as they ring in the new year. While the broader market enjoyed a year of...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls

January 02, 2026

Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...

Via MarketMinute

Topics Economy Intellectual Property World Trade

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026

January 02, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Near Year High ↗

January 01, 2026

Johnson & Johnson is nearing its 52-week high, driven by strong momentum and positive news, raising expectations for its upcoming earnings report amidst heightened sensitivity to market trends.

Via Talk Markets

Want Decades of Passive Income? 2 Stocks to Buy Right Now ↗

January 01, 2026

These income stocks could be great buys to add to your portfolio.

Via The Motley Fool

Topics Intellectual Property

The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings

December 31, 2025

As 2025 draws to a close, the pharmaceutical industry stands at a historic crossroads. The year was defined by a widening chasm between the "metabolic haves"—those profiting from the global obesity...

Via MarketMinute

Topics Economy Intellectual Property Law Enforcement

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.